Opportunity for All: Innovations Realizing on the Promise of Genomic Medicine

11:00 AM - 12:00 PM (PDT), Tuesday, June 14, 2022

Genomic medicines continues to move to the forefront with an expected growth to $95B in 2028 (from $23B in 2020).  Despite invention, discovery and development from biopharma for new types of modalities, optimal ways to effect genetic regulation in cells is continuously evolving and improving.  As seen from the innovation success achieved during the pandemic, commercial partners are creating solutions to this challenge and paving the path to fulfil the potential transformation of healthcare to make medicine more precise and personalized. Come join this panel of luminary leaders from companies of Danaher Corporation to discuss cutting edge solutions being used to deliver genomic medicines.

Sponsored By
Moderator
photo
Head, innovation Strategy, Cell Therapy
Danaher Corporation
Speakers
photo
General Manager, Gene Therapy
Pall Biotech
photo
GM Nucleic Acid Therapeutics
Cytiva
photo
Co-founder and CEO
Precision Nanosystems
photo
Chief Commercial Officer
Aldevron